Literature DB >> 3610833

A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation.

M Debono, M Barnhart, C B Carrell, J A Hoffmann, J L Occolowitz, B J Abbott, D S Fukuda, R L Hamill, K Biemann, W C Herlihy.   

Abstract

A21978C, produced by Streptomyces roseosporus, NRRL 11379, is a complex of new acidic lipopeptolide antibiotics which inhibits Gram-positive bacteria. HPLC separation of the various components from the purified complex resulted in the isolation of A21978C1, -C2 and -C3 (major components) and -C4, -C5, and -C0 (minor components). Each of these components was fermented with cultures of Actinoplanes utahensis (NRRL 12052) to give the identical inactive peptide ("A21978C nucleus") by removal of the fatty acid acyl groups from the N-terminus. This peptide was composed of 13 amino acids: L-kynurenine, L-threo-3-methylglutamic acid, L-asparagine, L-aspartic acid (3 residues), glycine (2 residues), L-tryptophan, L-ornithine, D-alanine, D-serine and L-threonine. The amino acid sequence was determined using a combination of the Edman degradation and gas chromatography mass spectrum (GC-MS) analysis of appropriately derivatized peptides obtained from partial hydrolysis. Each major component was shown to be acylated with a branched chain fatty acid at the N-terminus and the structure of this fatty acid was determined by 1H NMR and mass spectral methods. A structure for A21978C was assigned on the basis of this degradative and physico-chemical information.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610833     DOI: 10.7164/antibiotics.40.761

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  40 in total

Review 1.  [Biosynthesis of peptides: a non-ribosomal system].

Authors:  H Kleinkauf; H van Liempt; H Palissa; H von Döhren
Journal:  Naturwissenschaften       Date:  1992-04

Review 2.  Nonribosomal peptide synthetases involved in the production of medically relevant natural products.

Authors:  Elizabeth A Felnagle; Emily E Jackson; Yolande A Chan; Angela M Podevels; Andrew D Berti; Matthew D McMahon; Michael G Thomas
Journal:  Mol Pharm       Date:  2008-01-25       Impact factor: 4.939

3.  The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae.

Authors:  Vivian Miao; Renee Brost; Joanne Chapple; Kevin She; Marie-François Coëffet-Le Gal; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2005-10-06       Impact factor: 3.346

Review 4.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Molecular cloning and physical mapping of the daptomycin gene cluster from Streptomyces roseosporus.

Authors:  M A Mchenney; T J Hosted; B S Dehoff; P R Rosteck; R H Baltz
Journal:  J Bacteriol       Date:  1998-01       Impact factor: 3.490

6.  Retrospective analysis of natural products provides insights for future discovery trends.

Authors:  Cameron R Pye; Matthew J Bertin; R Scott Lokey; William H Gerwick; Roger G Linington
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

Review 7.  Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery.

Authors:  Lars Robbel; Mohamed A Marahiel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 8.  Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.

Authors:  William R Miller; Arnold S Bayer; Cesar A Arias
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

Review 9.  The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry.

Authors:  Thomas M Wood; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

10.  Use of multivariate analysis to compare antimicrobial agents on the basis of in vitro activity data.

Authors:  J M Hernández; P Conforti
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.